| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.80B | 5.89B | 6.12B | 5.55B | 5.30B | 4.63B |
| Gross Profit | 3.74B | 3.82B | 3.94B | 3.55B | 3.38B | 2.78B |
| EBITDA | 273.00M | 949.90M | 1.00B | 964.90M | 856.30M | 744.50M |
| Net Income | -382.90M | -367.90M | 89.40M | 508.20M | 259.50M | -201.30M |
Balance Sheet | ||||||
| Total Assets | 12.06B | 11.91B | 12.08B | 12.66B | 12.12B | 13.69B |
| Cash, Cash Equivalents and Short-Term Investments | 264.60M | 257.10M | 300.80M | 246.90M | 233.30M | 253.50M |
| Total Debt | 4.30B | 4.25B | 4.12B | 4.55B | 4.78B | 5.80B |
| Total Liabilities | 8.00B | 7.95B | 7.83B | 8.43B | 8.56B | 9.51B |
| Stockholders Equity | 3.79B | 3.69B | 3.97B | 3.95B | 3.30B | 3.90B |
Cash Flow | ||||||
| Free Cash Flow | 298.70M | 277.60M | 369.40M | 402.90M | 552.50M | 144.80M |
| Operating Cash Flow | 490.40M | 492.60M | 614.60M | 625.70M | 726.60M | 318.70M |
| Investing Cash Flow | -104.90M | -128.40M | -226.20M | -118.20M | 269.70M | 2.44B |
| Financing Cash Flow | -424.00M | -426.80M | -336.70M | -469.30M | -1.03B | -2.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $2.88B | 17.58 | 19.95% | 3.80% | 3.12% | 9.01% | |
68 Neutral | $5.37B | 63.78 | 8.77% | ― | 13.80% | -25.02% | |
64 Neutral | $1.45B | 16.09 | 4.92% | 3.15% | -5.21% | 1.96% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | $872.17M | 34.99 | 1.62% | 3.51% | -1.34% | -73.59% | |
56 Neutral | $41.46B | -44.54 | -20.73% | 1.30% | -6.36% | -554.84% | |
49 Neutral | $2.67B | -6.71 | -9.96% | ― | -5.68% | -358.36% |
On December 20, 2025, Coty’s board appointed former Procter & Gamble executive Markus Strobel as Executive Chairman and Interim CEO, effective January 1, 2026, with a significant compensation package of salary, bonus eligibility and long-term equity incentives tied to service and performance through 2028. Strobel, known for leading P&G’s Global Skin & Personal Care business and revitalizing prestige brands in Asia and other key regions, will guide Coty at what the company calls a pivotal moment, as it conducts a strategic review of its Consumer Beauty division and seeks to consolidate its leadership and profitable growth prospects in both prestige and mass beauty. The leadership changes also include the planned separation of CEO Sue Y. Nabi, who will step down and leave the board on December 31, 2025 under a separation agreement that provides cash in lieu of notice and partial vesting of restricted stock units, while other unvested equity is forfeited. In parallel, long-standing Chairman Peter Harf will resign from the board on December 31, 2025 after more than three decades of involvement, to be succeeded in board leadership by Strobel and joined by new director Patricia Capel, who will take a board seat and join the Remuneration and Nomination Committee on January 1, 2026, reflecting a broad reshaping of Coty’s top governance structure.
The most recent analyst rating on (COTY) stock is a Sell with a $3.00 price target. To see the full list of analyst forecasts on Coty stock, see the COTY Stock Forecast page.
On December 18, 2025, Coty JV Holding S.à r.l., an indirect subsidiary of Coty Inc., agreed to sell its remaining shareholdings in Rainbow JVCo, which represents Coty’s residual 25.8% stake in professional haircare group Wella, to KKR-managed entities for $750 million in cash plus a non-cash consideration that will give Coty JV a 45% equity interest in the buyer vehicle and rights to a significant share of future Wella exit proceeds. As part of the transaction, Coty JV entered into a new shareholders’ agreement that grants it consent rights on certain corporate actions at the buyer level, board observer rights, and tag-along and drag-along protections, while terminating a prior shareholders’ agreement related to Rainbow JVCo, and Coty expects to record an estimated non-cash impairment charge of approximately $200 million in the quarter ended December 31, 2025. The deal, announced on December 19, 2025, completes Coty’s multi-year program begun in 2020 to monetize and fully divest its Wella stake by the end of calendar 2025, simplifies Coty’s portfolio, and is intended to substantially reduce its financial net leverage through debt repayment using most of the $750 million upfront proceeds, reinforcing its deleveraging strategy and sharpening its strategic focus on core beauty operations.
The most recent analyst rating on (COTY) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on Coty stock, see the COTY Stock Forecast page.
On October 15, 2025, Coty Inc., along with its subsidiaries, completed a private offering of $900 million in senior notes due in 2031, with an interest rate of 5.600%. These notes are senior unsecured obligations and are subject to specific conditions regarding investment grade ratings, which could affect the company’s financial operations and obligations. The issuance was conducted under exemptions from the Securities Act, targeting qualified institutional buyers and non-U.S. persons.
The most recent analyst rating on (COTY) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Coty stock, see the COTY Stock Forecast page.